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Background:  Hyogo  is the  second  prefecture,  after Kanagawa,  to  enact  a smoking  ban  in public  places  in
Japan. The  effect  of  this  smoking  ban  on  acute  coronary  syndrome  (ACS)  has not  been evaluated.
Purpose:  Changes  in  the  annual  number  of  ACS hospital  cases  in  Hyogo  Prefecture,  before  and  after  the
enactment  of  the prefectural  legislative  ban  on smoking  in public  places,  are  to be  compared  with  those
in Gifu  Prefecture,  where  there  is no smoking-ban  legislation.
Methods:  Consecutive  Hyogo  residents  with ACS,  admitted  to  33 major  hospitals  in the Hanshin-Awaji-
Kobe  district,  which  covers  56%  of  the population,  during  the  12  months  before  implementation  of the
legislation  (April  2012  through  March  2013)  and  during  the  same  24  months  thereafter  (April  2013
through  March  2015)  will  be enrolled.  Consecutive  patients  with  ACS,  who  are  Gifu residents,  treated  at
the  20  major  hospitals  in  Gifu  Prefecture  will  be  enrolled  as geographical  controls.  The  primary  endpoint
is  the  change  in number  of ACS  admissions  from  April  2012  through  March  2015,  considering  the  periods
before  and  after  the  smoking-ban  legislation  in Hyogo  prefecture.
Conclusion:  Our study  has  certain  strengths:  (1) This  is  the  ﬁrst  large  Japanese  study  of ACS  registry  with
smoking-ban  legislation.  (2) Major  hospitals  in  the Hanshin-Awaji-Kobe  district  are  included.  (3) The
data  will  cover  3  years  including  1  year  before  legislation  enactment.  (4)  The  data  will be  compared  with
those  of  Gifu  Prefecture,  where  smoking-ban  legislation  will  not  be  enacted.  (5)  The  very  large  database
makes  possible  analysis  of  subgroups  based  on age  and  gender.© 2013  Jap
∗ Corresponding author. Tel.: +81 06 6482 1521.
E-mail addresses: gifuim-gif@umin.ac.jp,
ujiwarahisayoshi@amahosp.amagasaki.hyogo.jp (H. Fujiwara).
1 Members of the Smoking ban in public places in Hyogo prefecture: comparison
o Gifu (SHYOGI) study are listed in Appendix.
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.06.020anese  College  of Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.
Introduction
The adverse effects of exposure to environmental tobacco
smoke are now well established and several studies have shown
a higher risk of coronary artery diseases, lung cancer, respiratory
diseases, and stroke associated with both active and passive smok-
ing [1–3]. However, whether banning of smoking in public places
vier Ltd. All rights reserved.
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(Fig. 1) which covers approximately 3,150,000 people, 56% of
the population of Hyogo Prefecture. Gifu Prefecture, where
smoking-ban legislation will not be enacted, is the 17th most
populous prefecture in Japan (approximately 2,070,000 people),66 Y. Sato et al. / Journal of 
ould prevent acute coronary syndrome (ACS) was  unknown until
ecently. In 2002, a legislative ban on smoking in public places
as enacted in Helena district (Montana State) in the USA. The
ean number of patients with ACS admitted to St Peter’s Com-
unity Hospital showed a 40% reduction [4]. Similar reports have
een published in Europe and other parts of the USA. However,
hese were retrospective in design. Recently, a legislative ban on
moking in public places in Scotland was evaluated prospectively.
here was a 17% reduction in ACS [5]. A recent meta-analysis of
1 studies showed enactment of smoking-ban legislation in public
laces to reduce ACS by 17% [6,7].
Hyogo is the second prefecture to ban smoking in public places,
fter Kanagawa, in Japan. However, the association between enact-
ent of smoking-ban legislation and the incidence of ACS has
ot been studied in Japan. The aim of this study is to examine
he changes in numbers of ACS cases, before and after enactment
f the legislative ban on smoking in public places, presenting to
ajor hospitals in the Hanshin-Awaji-Kobe area of Hyogo Prefec-
ure. Changes in the number of ACS cases will be compared with
hose in Gifu prefecture where smoking-ban legislation will not be
nacted.
tudy design
The protocol is on the webpage of the University Hospital Medi-
al Information Network (UMIN) on April 2012 (UMIN000007797).
(http://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=
rows&action=brows&type=summary&recptno=R000009181&
anguage=J) [8].
atients
Consecutive Hyogo residents with ACS admitted to cardiology
nits in the 33 major hospitals of the Hanshin-Awaji-Kobe dis-
rict (Appendix), in Hyogo Prefecture during the 12 months before
mplementation of the legislation (April 2012 through March 2013)
nd during the 24 months thereafter (April 2013 through March
015) will be enrolled. The diagnosis of ASC will be based on the
urrent guidelines [9,10]. Patient information (Table 1) at the time
f hospitalization for ACS will be obtained from medical records.
onsecutive Gifu residents with ACS, treated at the cardiology units
f the major hospitals in Gifu Prefecture (Appendix) will be enrolled
s geographical controls.
All study procedures comply with the principles outlined in the
eclaration of Helsinki and the institutional guidelines of Hyogo
refectural Amagasaki Hospital. This is an observational study of
able 1
ase report form.
1. Name of institution Hospital
2. Date of acute coronary syndrome onset YY MM DD
3.  Category of acute coronary syndrome 1. Acute Myocardial Infarction
2. Unstable Angina
4.  Patient postal code (ﬁrst 3 digits only) XXX
5.  Sex Male/Female
6.  Age years
7.  Current smoker Yes/No
8.  History of hyperlipidemia Yes/No
9.  History of hypertension Yes/No
10. History of diabetes mellitus Yes/No
11. History of acute coronary syndrome Yes/No
eﬁnitions: Hypertension: systolic blood pressure ≥140 mmHg  and/or diastolic
lood pressure ≥90 mmHg, or currently treated with anti-hypertensive(s).
iabetes mellitus: Fasting blood glucose ≥126 mg/dL, random blood glucose
200 mg/dL or HbA1c ≥6.5% or currently treated with anti-diabetic drug(s).
yperlipidemia: total cholesterol ≥220 mg/dL and/or LDL-C ≥140 mg/dL, or cur-
ently treated with anti-hyperlipidemic(s).logy 63 (2014) 165–168
existing data such as medical charts, and no human samples will
be used. Because this study satisﬁes the criteria in Section 3-1 of
Ethical Guidelines for Epidemiological Studies from the Japanese
Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/
general/seido/kousei/i-kenkyu/ekigaku/0504sisin.html [11]),
informed consent from participants is not necessary. However,
informed consent will be obtained if it is judged necessary by the
independent ethics committees of participating institutions.
Endpoints
The primary endpoint is the change in number of ACS admis-
sions from April 2012 through March 2015, considering the periods
before and after the smoking-ban legislation in Hyogo prefecture.
Statistical analysis
The monthly number of ACS hospitalizations before and after
the legislation in the Hyogo and Gifu areas will be evaluated using
a generalized linear model based on a Poisson distribution. This
model will be adjusted by gender, age group, smoking status, postal
code, risk factors (hypertension, diabetes mellitus, and hyperlipi-
demia), and season.
Discussion
Location and population
Hyogo Prefecture, with a population of approximately
5,580,000, was the 7th most populous prefecture in Japan as
of October 2011, with an annual population reduction rate of 0.11%
in 2011 and 0.04% in 2010 (Homepage of the Ministry of Internal
Affairs and Communications, Statistics Bureau: http://www.stat.
go.jp/data/jinsui/2011np/index.htm). The 33 hospitals listed in
Appendix are all major hospitals (Japanese Circulation Soci-
ety: http://www.j-circ.or.jp/information/senmoni/senmoni
shiteibyouin.htm) [12] in the Hanshin-Awaji-Kobe districtFig. 1. Hanshin-Awaji-Kobe district. This district covers large cities including Kobe
and  includes 56% of the population of Hyogo Prefecture.
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ith an annual population reduction rate of 0.47% in 2011 and
.50% in 2010. The distance between Hyogo and Gifu Prefectures
s approximately 200 km.  Smoking rates of the two prefec-
ures were quite similar from 2001 to 2010 (2001, 28.5%; 2004,
6.5%; 2007, 23.3%; 2010, 19.0% in Hyogo Prefecture vs. 2001,
8.6%; 2004, 27.7%; 2007, 23.7%; 2010, 19.5% in Gifu Prefecture;
ttp://ganjoho.jp/professional/statistics/statistics.html#07) [13].
Although the World Health Organization (WHO) launched an
nitiative to monitor temporal trends in coronary heart disease,
apan was not included in this study and nationwide data thus are
ot available. However, in accordance with the WHO-Monitoring
rends and Determinants in Cardiovascular Disease (MONICA)
tudy, the Takashima AMI  (acute myocardial infarction) Registry
eported the incidence rate of AMI  to be 62/100,000 persons/years
14]. The MIYAGI-AMI registry reported the incidence rate of AMI
o be 27/100,000 persons/year [15]. Therefore, with populations
f 3,000,000 in the Hanshin-Awaji-Kobe district, more than 1000
ases would be expected in one year.
yogo Prefectural smoking ban
The “Hyogo Prefectural Ordinance on Prevention of Expo-
ure to Second-hand Smoke,” adopted in March 2012, to
e enforced in April 2013, aims to “prevent negative health
mpacts due to second-hand smoke by promoting smoke-free
nvironments. Penalties are to be imposed on violators from
ctober 2014. The relevant information was posted on a spe-
ial site created on the ofﬁcial website (Second-hand Smoke
revention Ofﬁce, Health Promotion Division, Public Health
ureau, Health & Welfare Department, Hyogo Prefectural Govern-
ent: http://web.pref.hyogo.lg.jp/hw13/hw13 000000005.html)
16]. The level of adherence to the Hyogo anti-smoking legislation
s as yet unknown. However, this social legislation and a related
ampaign are anticipated to reduce not only second-hand smoke
n public places, but also to possibly reduce the actual smoking rate.
moking and ACS
Prevention and cessation of smoking are the standard of care
or cardiovascular risk reduction. The main mechanism of cardio-
ascular injury with acute and chronic smoking is considered to be
icotine-induced dysfunction and damage to vascular endothelial
ells via rising oxidative stress and impairment of vessel dilata-
ion. In addition, smoking increases the release of norepinephrine
nd epinephrine. These vasoconstrictive effects and endothelial
amage are considered to play important roles in the pathogen-
sis on smoking-dependent arteriosclerosis and/or plaque rupture
ith thrombi [17–19]. Secondhand smoke (SHS) is also consid-
red to predispose to ACS [20,21]. In nonsmokers, brief exposure to
HS has been associated with changes in platelet activation, vascu-
ar elasticity, endothelial function, heart rate variability, and lipid
etabolism. The aim of smoking legislation is to not only reduce
moking among smokers, but also protect nonsmokers from SHS.
In other countries, smoking is considered to be the most pre-
entable cause of death in the world today, and smoking-ban
egislation in public places and workplaces have been instituted
n several countries. Meyers and He recently reported that ACS risk
ecreased by 17% in a meta-analysis of 11 reports on smoking-ban
egislation in public places [6]. Compared with developed countries
n the West, Japan is presently still a developing country with
espect to programs that ban smoking. Although Kanagawa is the
rst prefecture in Japan to pass a no-smoking ordinance, a study
omparing rates of ACS in Kanagawa before and after the smoking-
an legislation has not yet been reported. Hyogo is the second
refecture, after Kanagawa, to enact a smoking ban in public places
n Japan, and the primary endpoint of this study is the change inlogy 63 (2014) 165–168 167
number of ACS admissions from April 2012 through March 2015,
before and after the smoking-ban legislation in Hyogo Prefecture.
Although smoking-ban legislation has been reported to reduce
the number of ACS, the age effect on the reduction of ACS after
smoking-ban legislation is controversial. Some studies have shown
a greater effect in younger patients. Furthermore, the ACS reduc-
tion rates may  differ between males and females, but this is also
controversial [6,22]. These age and gender factors should be fur-
ther examined employing a Japanese database as there might be
social and racial differences.
Limitations and strengths
This study has several limitations. First, unobserved confound-
ing variables between Hyogo and Gifu Prefecture will not be
adjusted for. Second, clinical background details of ACS will not
be measured. Lastly, we will not measure the change in smoking
prevalence nor make any direct observation to measure reduc-
tion of exposure to SHS. However, as this study should include all
admitted ACS patients, the protocol should be very simple in the
real-world situation. Indeed, a review article showed that many
other studies of ACS before and after smoking-ban legislation also
did not adjust for geographical backgrounds, consider clinical back-
ground details, or measure the change of smoking prevalence or
exposure to SHS [6,23,24].
Our study has certain strengths: (1) This is the ﬁrst large
Japanese study of ACS registry with smoking-ban legislation; (2)
Major hospitals in the Hanshin-Awaji-Kobe district are included;
(3) The data will available for three years including one year before
legislation enactment; (4) The data will be compared with those of
Gifu Prefecture where smoking-ban legislation will not be enacted;
(5) The very large database makes possible analysis of subgroups
based on age and gender.
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Study chair:
Hisayoshi Fujiwara, Hyogo Prefectural Amagasaki Hospital
Study coordinating center chair of Gifu Prefecture:
Shinya Minatoguchi, Gifu University
Study operations committee:
Yukihito Sato, Hyogo Prefectural Amagasaki Hospital
Kazuhiko Nishigaki, Gifu University
Mami  Iida, Gifu Prefectural General Medical Center
Study coordinating committee:
Ken-ichi Hirata, Kobe University Graduate School of Medicine
Tohru Masuyama, Hyogo College of Medicine
Yutaka Furukawa, Kobe City Medical Center General Hospital
Masaaki Uematsu, Kansai Rosai Hospital
Junichi Yoshikawa, Nishinomiya Watanabe Cardiovascular Center
Satoru Otsuji, Higashi Takarazuka Satoh Hospital
Participating hospitals and collaborators of Hyogo Prefec-
ture.
1. Kobe University Graduate School of Medicine: K Hirata, T
Shinke, M Kuroda
2. Kobe City Medical Center General Hospital: Y Furukawa, K Kim
3. Kobe Rosai Hospital: N Inoue
4. Shinko Hospital: M Iwahashi
5. Japanese Red Cross Kobe Hospital: T Doi
6. Shakaihoken Kobe Central Hospital: T Otomo
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7. Saiseikai Hyogoken Hospital: W Yamochi
8. Nishikobe Medical Center: H Eizawa
9. Kawasaki Hospital: T Maruyama
0. National Hospital Organization Kobe Medical Center: M
Shimizu
1. Kobe Ekisaikai Hospital: H Fuji, H Hayashi
2. Kobe Tokushukai Hospital: T Nojima, Y Sutani
3. Maikodai Hospital: S Kinugasa
4. Hyogo Prefectural Awaji Medical Center: A Takarada, S Kim
5. Rokko Island Hospital: T Inoue, S Mikami
6. Ookuma Central Hospital: J Tateishi
7. Hyogo Prefectural Amagasaki Hospital: Y Takatsu
8. Kansai Rosai Hospital: M Uematsu, M Awata
9. Showa Hospital Saibikai: H Yasumoto, S Nagayama, M Kakishita
0. Amagasaki Chuou Hospital: J Yoshida
1. Nishinomiya Watanabe Cardiovascular Center: J Yoshikawa, T
Iwamura
2. Hyogo Prefectural Nishinomiya Hospital: Y Chimori, T Mat-
suoka
3. Meiwa Hospital: S Nakao
4. Hyogo College of Medicine: T Masuyama, K Fujii
5. Kinki Central Hospital: M Izumi
6. Itami City Hospital: H Shimoyama
7. Takarazuka City Hospital: T Koide, K Tanabe
8. Higashi Takarazuka Satoh Hospital: S Otsuji
9. Kyoritsu Hospital: K Kobayashi
0. Kobe City Hospital Organization Kobe City Medical Center West
Hospital: K Shiratori, S Moriwaki
1. Akashi Medical Center: M Kawata
2. Takahashi Hospital: A Takahashi, N Taniguchi
3. Hyogo Prefectural Tsukaguchi Hospital: Y Kita
Participating hospitals and collaborators of Gifu Prefecture.
1. Gifu Heart Center Department of Cardiovascular Medicine: K
Ueno, M Okubo
2. Gifu Municipal Hospital: S Ojio, N Tsugita
3. Murakami Memorial Hospital Asahi University: H Ohashi, T
Segawa
4. Gifu Prefectural General Medical Center: S Watanabe, M Iida
5. Ibi Kousei Hospital: T Tsukamoto, M Nakagawa
6. Department of Cardiology & Respirology, Gifu University Grad-
uate School of Medicine: S Minatoguchi, K Nishigaki
7. Gihoku Kousei Hospital: T Takaya,
8. Chuno Kosei Hospital: H Takatsu, M Koda
9. Matsunami General Hospital: N Morita, Y Kojima
0. Hashima Municipal Hospital: Y Osumi, K Watanabe
1. Japanese Red Cross Gifu Hospital: K Nagashima, H Kobayashi
2. National Hospital Organization Nagara Medical Center: I Nishio
3. Ogaki Municipal Hospital: T Sone, H Tsuboi, R Furuta
4. Tokai Central Hospital: S Ogawa, I Uchida
5. Kizawa Memorial Hospital: S Miyata
6. Gifu Prefectural Tajimi Hospital: K Yokoi, H Horibe
7. Nakatsugawa Municipal General Hospital: K Hayashi
8. Toki General Hospital: K Okumura, H Tsukamoto
9. Japanese Red Cross Takayama Hospital: E Horibe
0. Gifu Prefectural Gero Hot Spring Hospital: T Ohira, Y Oieferences
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